Results 1 to 10 of about 297,244 (376)

Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong

open access: yesInternational Journal of Cancer, 2019
Aspirin, commonly used for prevention of cardiovascular and cerebrovascular diseases, has been found to possess protective effects against cancer development in the Western populations. Such effects among Asian populations remain uncertain. The objective
Kelvin Tsoi   +2 more
exaly   +2 more sources

The prevalence and associated factors of aspirin resistance among prophylactic aspirin users [PDF]

open access: yesRomanian Journal of Neurology, 2021
Background. Aspirin is an antiplatelet used for the secondary prevention after vascular events. It is also suggested for the primary prevention of vascular events in high risk people, however, despite using standard prophylactic doses, aspirin resistance
Samaneh Ghorbani-Shirkouhi   +5 more
doaj   +1 more source

Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review

open access: yesJournal of Cardiovascular Development and Disease, 2023
Aspirin inhibits platelet function by irreversibly inhibiting the synthesis of thromboxane A2 (TxA2). Aspirin, at low doses, is widely used for cardiovascular prevention. Gastrointestinal discomfort, mucosal erosions/ulcerations and bleeding are frequent
Bianca Clerici, Marco Cattaneo
doaj   +1 more source

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.

open access: yesJournal of the American Medical Association (JAMA), 2022
Importance Cardiovascular disease (CVD) is the leading cause of mortality in the US, accounting for more than 1 in 4 deaths. Each year, an estimated 605 000 people in the US have a first myocardial infarction and an estimated 610 000 experience a first ...
K. Davidson   +17 more
semanticscholar   +1 more source

Aspirin [PDF]

open access: yesCirculation, 2000
Acetylsalicylic acid, or aspirin, is a synthetic compound with antipyretic, analgesic, anti-inflammatory, and antiplatelet properties. Since its introduction into the commercial market in June 1899, it has become one of the most versatile pharmaceutical agents known, with demonstrated efficacy in a myriad of clinical settings.
Eric H. Awtry, Joseph Loscalzo
openaire   +3 more sources

Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy

open access: yesFrontiers in Oncology, 2022
Gonadotropin-releasing hormone (GnRH) therapy has been known to increase risks of major adverse cardiovascular and cerebrovascular events (MACCEs). Herein, we aim to estimate whether regular use of aspirin attenuates risks of MACCEs in prostate cancer ...
Wei-Ting Chang   +15 more
doaj   +1 more source

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Background Aspirin is important for preventing thrombotic events but also increases bleeding complications. Minimizing bleeding while preventing thrombotic events remains challenging in patients undergoing coronary artery bypass grafting (CABG ...
Laura M. Willemsen   +10 more
doaj   +1 more source

The dissolution of aspirin and aspirin tablets [PDF]

open access: yesJournal of Pharmacy and Pharmacology, 1967
Abstract An attempt has been made to standardize the “beaker” method of measuring in vitro dissolution rates of tablets against published data for aspirin. An unexpected problem arose when it was found that samples of commercial aspirin have different intrinsic dissolution rates.
Dorothy J. Saville, A. G. Mitchell
openaire   +2 more sources

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects

open access: yesPharmaceutics, 2023
Acid-reducing agents are commonly used for the prevention of aspirin-induced gastrointestinal complications such as peptic ulcers. As a novel potassium-competitive acid blocker, fexuprazan is expected to prevent aspirin-induced gastrointestinal ...
JungJin Oh   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy